|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.280 USD | +9.33% |
|
+8.23% | -10.10% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 99.66M 87.18M 80.39M 74.39M 141M 9.51B 144M 963M 377M 4.67B 374M 366M 16.18B | P/E 2026 * |
1.25x | P/E 2027 * | 5.94x |
|---|---|---|---|---|---|
| Enterprise Value | 99.66M 87.18M 80.39M 74.39M 141M 9.51B 144M 963M 377M 4.67B 374M 366M 16.18B | EV / Sales 2026 * |
1.25x | EV / Sales 2027 * | 0.74x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +9.33% | ||
| 1 week | +8.23% | ||
| Current month | +7.52% | ||
| 1 month | +12.29% | ||
| 3 months | +37.09% | ||
| 6 months | -23.48% | ||
| Current year | -10.10% |
| 1 week | 2.87 |  | 3.32 |
| 1 month | 2.7 | | 3.35 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.77 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 19/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 21/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 30/11/2008 |
| Chairman | 71 | 19/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 31/05/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Free | Chief Financial Officer | 400,000 | 1.2041% | ||
| 03-31 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-17 | Free | Chief Executive Officer | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.33% | +8.23% | +65.34% | -61.75% | 99.66M | |
| +0.76% | +1.82% | +20.55% | -5.29% | 67.44B | |
| +0.52% | -5.52% | +46.80% | +218.71% | 53.98B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 41.77B | |
| +0.99% | +6.05% | -48.96% | -52.97% | 41.15B | |
| -0.43% | -7.35% | +50.53% | -28.89% | 29.58B | |
| +3.50% | -4.09% | +133.29% | -37.85% | 29.28B | |
| +1.20% | +1.59% | +72.76% | +91.82% | 23.43B | |
| +0.17% | +8.48% | +4.86% | +185.45% | 19.11B | |
| +1.14% | -0.17% | +68.83% | +134.48% | 16.82B | |
| Average | +1.45% | +0.87% | +44.65% | +47.62% | 32.27B | |
| Weighted average by Cap. | +0.46% | +1.05% | +36.00% | +51.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.88M 64.44M 59.62M 113M 7.62B 115M 772M 302M 3.74B 300M 293M 12.97B | 134M 117M 108M 100M 190M 12.8B 193M 1.3B 508M 6.29B 504M 493M 21.78B |
| Net income | 90.51M 79.18M 73.02M 67.56M 128M 8.64B 130M 874M 343M 4.24B 340M 332M 14.7B | 21.13M 18.49M 17.05M 15.77M 29.94M 2.02B 30.44M 204M 80.03M 990M 79.33M 77.61M 3.43B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$3.290 | +9.67% | 883,449 |
| 08/07/26 | US$3.000 | +0.33% | 411,261 |
| 07/07/26 | US$2.990 | +1.36% | 391,742 |
| 06/07/26 | US$2.950 | -2.96% | 413,297 |
| 02/07/26 | US$3.040 | -1.62% | 332,636 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
